Table 2.
Primary and secondary outcomes at baseline, 6-months and 12-months.
| Intervention |
Control |
Coefficient [95% CI]a | p-value | ||||
|---|---|---|---|---|---|---|---|
| n | mean (SD) | n | mean (SD) | ||||
| MANSA | Baseline | 37 | 4.0 ± 0.7 | 35 | 4.2 ± 0.5 | … | … |
| 6 months | 31 | 4.5 ± 1.0 | 32 | 4.2 ± 0.6 | −0.22 [-0.61 – 0.17] | 0.167 | |
| 12 months | 28 | 4.5 ± 1.0 | 30 | 4.0 ± 0.5 | −0.52 [-0.89 to −0.15] | 0.007 | |
| SIX | Baseline | 37 | 4.3 ± 1.4 | 35 | 4.7 ± 1.2 | … | … |
| 6 months | 31 | 4.2 ± 1.1 | 32 | 4.6 ± 1.1 | 0.32 [-1.79 – 2.44] | 0.764 | |
| 12 months | 28 | 4.5 ± 1.2 | 30 | 4.3 ± 1.2 | 1.20 [-0.07 – 2.46] | 0.063 | |
| BPRS | Baseline | 37 | 39.0 ± 7.0 | 35 | 36.0 ± 6.0 | … | … |
| 6 months | 31 | 34.2 ± 6.6 | 32 | 37.2 ± 5.7 | 4.04 [0.65–7.44] | 0.021 | |
| 12 months | 28 | 34.1 ± 6.7 | 30 | 40.2 ± 4.2 | 7.03 [3.34–10.72] | <0.001 | |
| DASS (depression) | Baseline | 37 | 20.2 ± 12.9 | 35 | 16.9 ± 10.2 | … | … |
| 6 months | 31 | 13.4 ± 12.0 | 32 | 17.9 ± 12.5 | 0.54 [0.28–0.79] | <0.001 | |
| 12 months | 28 | 6.9 ± 5.5 | 30 | 11.3 ± 4.9 | 5.24 [2.39–8.10] | 0.001 | |
| DASS (anxiety) | Baseline | 37 | 18.7 ± 11.5 | 35 | 15.4 ± 10.7 | … | … |
| 6 months | 31 | 13.5 ± 10.7 | 32 | 16.3 ± 10.7 | 0.71 [0.47–0.94] | <0.001 | |
| 12 months | 28 | 5.8 ± 4.8 | 30 | 9.8 ± 4.7 | 5.71 [2.96–8.46] | <0.001 | |
a
For the MANSA, SIX and DASS scales, regression coefficients derived from mixed linear models with a fixed effect for treatment and baseline scores and a random effect for clinician cluster. For the SIX proportional odds models with treatment fitted as a fixed effect and a random intercept.